Good News!
A Johns Hopkins researcher has claimed antibodies from recovered coronavirus patients could help protect people at risk
A treatment that can be made readily available under urgent circumstances, a team from Johns Hopkins alongside many other researchers are studying whether or not the antibodies of those recovered from the coronavirus could help protect at-risk humans from the virus.
“Deployment of this option requires no research or development,” immunologist Arturo Casadevall told Science Alert. “It could be deployed within a couple of weeks since it relies on standard blood-banking practices.” Not to mention, a Japanese pharmaceutical company is nearing approval of the treatment.
We Publish News 24/7. Don’t Miss A Story. Click HERE to SUBSCRIBE to Our Newsletter Now!
